The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction
Authors
Keywords
-
Journal
JOURNAL OF CARDIAC FAILURE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.cardfail.2023.10.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
- (2023) Gerasimos Filippatos et al. CIRCULATION
- Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis
- (2023) Fraser J. Graham et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: a Bayesian meta‐analysis
- (2023) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
- (2023) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Ferric Carboxymaltose in Heart Failure with Iron Deficiency
- (2023) Robert J. Mentz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF
- (2022) Kieran F. Docherty et al. JACC-Heart Failure
- Rationale and design of a randomised trial of intravenous iron in patients with heart failure
- (2022) Paul R Kalra et al. HEART
- Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
- (2022) Paul R Kalra et al. LANCET
- Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐ Reduced
- (2021) João Pedro Ferreira et al. EUROPEAN JOURNAL OF HEART FAILURE
- The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials
- (2020) Emilia Bagiella et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2020) Stefan D Anker et al. EUROPEAN HEART JOURNAL
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
- (2020) Piotr Ponikowski et al. LANCET
- The Burden of Iron Deficiency in Heart Failure
- (2018) Bruno M.L. Rocha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis
- (2016) Vojtech Melenovsky et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure
- (2016) John G. F. Cleland et al. JAMA Cardiology
- Systemic Iron Homeostasis
- (2013) Tomas Ganz PHYSIOLOGICAL REVIEWS
- Iron deficiency: an ominous sign in patients with systolic chronic heart failure
- (2010) E. A. Jankowska et al. EUROPEAN HEART JOURNAL
- Molecular Changes in Myocardium in the Course of Anemia or Iron Deficiency
- (2010) Ewa A. Jankowska et al. Heart Failure Clinics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started